{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:26:47Z","timestamp":1790713607385,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004162","name":"Meath Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.bpobgyn.2011.04.005","type":"journal-article","created":{"date-parts":[[2011,6,19]],"date-time":"2011-06-19T07:07:08Z","timestamp":1308467228000},"page":"605-615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Histology of cervical intraepithelial neoplasia and the role of biomarkers"],"prefix":"10.1016","volume":"25","author":[{"given":"Cara M.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"O\u2019Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2011.04.005_bib1","series-title":"GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet].Lyon","author":"Ferlay","year":"2010"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib2","series-title":"Colposcopy and treatment of cervical intraepithelial neoplasia: a beginners manual","first-page":"13","article-title":"An introduction to cervical intraepithelial neoplasia (CIN)","year":"2003"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"zur Hausen","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/CS20050369","article-title":"Molecular biology of human papillomavirus infection and cervical cancer","volume":"110","author":"Doorbar","year":"2006","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib6","first-page":"503","article-title":"Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada","volume":"163","author":"Sellors","year":"2000","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib7","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1038\/sj.bjc.6602648","article-title":"Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN)","volume":"92","author":"Andersson","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib8","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ygyno.2004.08.033","article-title":"Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears","volume":"95","author":"Derchain","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bpobgyn.2005.02.002","article-title":"Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix","volume":"19","author":"Tjalma","year":"2005","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jmv.20062","article-title":"Human papillomavirus type specific DNA and RNA persistence\u2013implications for cervical disease progression and monitoring","volume":"73","author":"Cuschieri","year":"2004","journal-title":"J Med Virol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib11","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/ijc.20839","article-title":"Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: a 2-year follow-up of women with ASCUS or LSIL Pap smear","volume":"114","author":"Molden","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/oxfordjournals.jncimonographs.a003477","article-title":"Cofactors in human papillomavirus carcinogenesis\u2013role of parity, oral contraceptives, and tobacco smoking","volume":"31","author":"Castellsagu\u00e9","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib13","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/AOG.0b013e3181fe777f","article-title":"Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women","volume":"116","author":"Moscicki","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(04)17354-6","article-title":"Regression of low-grade squamous intra-epithelial lesions in young women","volume":"364","author":"Moscicki","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib15","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1067\/mob.2003.461","article-title":"Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy","volume":"188","author":"Cox","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib16","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/jnci\/djh104","article-title":"Projected clinical benefits and cost-effectiveness of a human papillomavirus 16\/18 vaccine","volume":"96","author":"Goldie","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/AOG.0b013e31818f5008","article-title":"Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1470-2045(08)70110-4","article-title":"Heterogeneity in CIN3 diagnosis","volume":"9","author":"Schiffman","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jnci\/djq001","article-title":"Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2\/3: critical role of duration of infection","volume":"102","author":"Rodr\u00edguez","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/LGT.0b013e318159408b","article-title":"2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ","volume":"11","author":"Wright","year":"2007","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib21","doi-asserted-by":"crossref","first-page":"e1000318","DOI":"10.1371\/journal.ppat.1000318","article-title":"Establishment of human papillomavirus infection requires cell cycle progression","volume":"5","author":"Pyeon","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/MMBR.68.2.362-372.2004","article-title":"Pathogenesis of human papillomaviruses in differentiating epithelia","volume":"68","author":"Longworth","year":"2004","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2050","article-title":"The natural history of cervical HPV infection: unresolved issues","volume":"7","author":"Woodman","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1309\/AJCPBRK7D1YIUWFP","article-title":"The reproducibility of CIN diagnoses among different pathologists: data from histology reviews from a multicenter randomized study","volume":"132","author":"Dalla Palma","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib25","first-page":"277","article-title":"Discrepancy in the interpretation of cervical histology by gynecologic pathologists","volume":"100","author":"Parker","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib26","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/jcp.49.10.833","article-title":"Interobserver variation in the reporting of cervical colposcopic biopsy specimens: comparison of grading systems","volume":"49","author":"McCluggage","year":"1996","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/jcp.42.3.231","article-title":"Observer variability in histopathological reporting of cervical biopsy specimens","volume":"42","author":"Robertson","year":"1989","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib28","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study","volume":"285","author":"Stoler","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF03256249","article-title":"Gene discovery in cervical cancer: towards diagnostic and therapeutic biomarkers","volume":"11","author":"Martin","year":"2007","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1471-0528.2010.02519.x","article-title":"The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial","volume":"117","author":"Cotton","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib31","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0002-9378(03)00413-7","article-title":"A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations","volume":"188","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib32","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0002-9378(03)00418-6","article-title":"Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance","volume":"188","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib33","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1158\/1055-9965.EPI-08-0508","article-title":"Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears","volume":"17","author":"Szarewski","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib34","article-title":"HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review","author":"Burger","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib35","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/path.1316","article-title":"Low- and high-risk CIN 1 and 2 lesions: prospective predictive value of grade, HPV, and Ki-67 immuno-quantitative variables","volume":"199","author":"Kruse","year":"2003","journal-title":"J Pathol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH719>3.0.CO;2-E","article-title":"The HS. Ki-67 immunoquantitation in cervical intraepithelial neoplasia (CIN): a sensitive marker for grading","volume":"193","author":"Kruse","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00000478-200201000-00008","article-title":"Diagnostic accuracy of cervical low-grade squamous intraepithelial lesions is improved with MIB-1 immunostaining","volume":"26","author":"Pirog","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib38","first-page":"13","article-title":"Ki67 predicts progression in early CIN: validation of a multivariate progression-risk model","volume":"26","author":"Kruse","year":"2004","journal-title":"Cell Oncol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib39","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.humpath.2008.12.005","article-title":"p16, Ki-67, and BD ProExC immunostaining: a practical approach for diagnosis of cervical intraepithelial neoplasia","volume":"40","author":"Walts","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jcp.56.1.56","article-title":"p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears","volume":"56","author":"Murphy","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib41","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/jcp.2004.018895","article-title":"p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer","volume":"58","author":"Murphy","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib42","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ijc.1174","article-title":"Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri","volume":"92","author":"Klaes","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib43","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0002-9440(10)65689-1","article-title":"Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions","volume":"153","author":"Sano","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib44","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1158\/1055-9965.1355.13.8","article-title":"Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population based cohort in Costa Rica","volume":"13","author":"Wang","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib45","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S1470-2045(08)70208-0","article-title":"Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial","volume":"9","author":"Carozzi","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib46","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s00428-004-1127-9","article-title":"p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri","volume":"445","author":"Negri","year":"2004","journal-title":"Virchows Arch"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib47","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ctrv.2008.10.005","article-title":"p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and metaanalysis","volume":"35","author":"Tsoumpou","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/dc.20175","article-title":"p16(INK4A) is a surrogate biomarker for a subset of human papilloma virus-associated dysplasias of the uterine cervix as determined on the Pap smear","volume":"32","author":"Bose","year":"2005","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/00313020500058607","article-title":"p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: experience with squamous lesions in 189 consecutive cervical biopsies","volume":"37","author":"Dray","year":"2005","journal-title":"Pathology"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib50","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1136\/jcp.2010.078634","article-title":"p16(INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions","volume":"63","author":"Dijkstra","year":"2010","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.pgp.0000236942.51840.56","article-title":"The negative predictive value of p16INK4a to assess the outcome of cervical intraepithelial neoplasia 1 in the uterine cervix","volume":"26","author":"Hariri","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib52","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1309\/0UP5PJK9RYF7BPHM","article-title":"Estimation of prognoses for cervical intraepithelial neoplasia 2 by p16INK4a immunoexpression and high-risk HPV in situ hybridization signal types","volume":"128","author":"Omori","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib53","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1309\/AJCPXSVCDZ3D5MZM","article-title":"Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia","volume":"133","author":"Bergeron","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib54","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00000478-200211000-00001","article-title":"p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia","volume":"26","author":"Klaes","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib55","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.MP.0000077518.78046.0C","article-title":"p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types","volume":"16","author":"Agoff","year":"2003","journal-title":"Mod Pathol"},{"issue":"331","key":"10.1016\/j.bpobgyn.2011.04.005_bib56","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.virol.2004.09.045","article-title":"Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy","volume":"20","author":"Santin","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib57","first-page":"1927","article-title":"Identification of cervical cancer markers by cDNA and tissue microarrays","volume":"15","author":"Chen","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib58","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1034\/j.1600-0463.2000.d01-46.x","article-title":"Expression of topoisomerase II and Ki-67 in cervical carcinoma\u2013clinicopathological study using immunohistochemistry","volume":"108","author":"Davidson","year":"2000","journal-title":"APMIS"},{"issue":"suppl 1","key":"10.1016\/j.bpobgyn.2011.04.005_bib59","first-page":"214A","article-title":"Evaluation of p16, MCM2, DNA Topoisomerase IIA and ProExC in cervical squamous intraepithelial lesions","volume":"87","author":"Shi","year":"2007","journal-title":"Lab Investig"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib60","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.71.110601.135425","article-title":"DNA replication in eukaryotic cells","volume":"71","author":"Bell","year":"2002","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib61","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1242\/jcs.114.8.1447","article-title":"Initiating DNA synthesis: from recruiting to activating the MCM complex","volume":"114","author":"Lei","year":"2001","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib62","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mrfmmm.2004.05.026","article-title":"Geminin-Cdt1 balance is critical for genetic stability","volume":"569","author":"Saxena","year":"2005","journal-title":"Mutat Res"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib63","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1046\/j.1432-1033.2003.03440.x","article-title":"Enhanced expression of Mcm proteins in cancer cells derived from uterine cervix","volume":"270","author":"Ishimi","year":"2003","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib64","doi-asserted-by":"crossref","first-page":"8386","DOI":"10.1158\/1078-0432.CCR-04-1029","article-title":"Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis","volume":"10","author":"Ha","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib65","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/modpathol.3800361","article-title":"Quantitation of CDC6 and MCM5 mRNA in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix","volume":"18","author":"Murphy","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib66","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/PAS.0b013e31815bbb69","article-title":"A sensitive and specific marker of HPV-associated squamous lesions of the cervix","volume":"32","author":"Badr","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib67","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1309\/AJCP1LLX8QMDXHHO","article-title":"Efficacy of p16 and ProExC immunostaining in the detection of high-grade cervical intraepithelial neoplasia and cervical carcinoma","volume":"135","author":"Guo","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib68","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrc968","article-title":"Validating survivin as a cancer therapeutic target","volume":"3","author":"Altieri","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib69","first-page":"805","article-title":"Expression of survivin in CIN and invasive squamous cell carcinoma of uterine cervix","volume":"22","author":"Kim","year":"2002","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib70","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1309\/L8BWF431WU9AC8FJ","article-title":"Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer","volume":"124","author":"Branca","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib71","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1099\/vir.0.81067-0","article-title":"Effects of human papillomavirus type 16 oncoproteins on survivin gene expression","volume":"87","author":"Borbely","year":"2006","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib72","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s001090050170","article-title":"B-MYB, a repressed trans-activating protein","volume":"75","author":"Ansieau","year":"1997","journal-title":"J Mol Med"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib73","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1006\/bcmd.2001.0399","article-title":"Regulation of the cell cycle by B-Myb","volume":"27","author":"Bessa","year":"2001","journal-title":"Blood Cell Mol Dis"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib74","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.ejca.2005.08.004","article-title":"B-MYB, a transcription factor implicated in regulating cell cycle, apoptosis and cancer","volume":"41","author":"Sala","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.04.005_bib75","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/j.1460-2075.1994.tb06330.x","article-title":"HPV16 E7 oncoprotein deregulates B-myb expression:correlation with targeting of p107\/E2F complexes","volume":"13","author":"Lam","year":"1994","journal-title":"EMBO J"},{"issue":"2","key":"10.1016\/j.bpobgyn.2011.04.005_bib76","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/IGC.0b013e318205759f","article-title":"MYBL2 (B-MYB) in cervical cancer: putative biomarker","volume":"21","author":"Astbury","year":"2011","journal-title":"Int J Gynecol Cancer"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693411000721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693411000721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:08:18Z","timestamp":1761498498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693411000721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":76,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1521693411000721"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2011.04.005","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histology of cervical intraepithelial neoplasia and the role of biomarkers","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2011.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}